Imaging study for lung cancer surgery planning
Treatments studied
Part of Cancer, Lungs & breathing clinical trials.
This trial tests a special imaging drug (18F-Alfatide) given as a shot before a PET/CT scan. It helps doctors see if non-small cell lung cancer has spread to lymph nodes, which could help plan your surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have non-small cell lung cancer and are scheduled for lung cancer surgery to remove the tumor and nearby lymph nodes.
- You are able to take care of yourself (fully active or able to do light work).
- You do not have serious kidney disease or uncontrolled diabetes.
- You are not pregnant or breastfeeding, and you are willing to use birth control during and after the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single dose of a special dye (LS301-IT) that helps surgeons see lung cancer cells more clearly during surgery. It aims to make lung cancer removal more precise and complete.
This trial tests a new imaging agent (68Ga-FL-031) to see if it can help find and stage tumors in people with small cell lung cancer, breast cancer, nasopharyngeal cancer, or other cancers. The goal is to improve diagnosis and treatment planning.
This trial tests a new type of PET scan that uses a special tracer to find lung tumors. The goal is to see if this scan can better detect cancer cells, which may help doctors plan the best treatment for you.
This study uses a special PET/CT scan that targets a protein called c-Met to help diagnose and stage non-small cell lung cancer. It aims to see if this imaging method can better identify tumor locations and characteristics.
This trial tests a newer PET/CT scan method to detect uncertain (indeterminate) lung nodules more accurately before biopsy or surgery. If you have a small lung nodule that doctors are still unsure about, this could help improve how nodules are found and assessed.
This study tests whether a special imaging scan using a radioactive sugar (18F-FDG) can help doctors better examine lung cancer tissue during thoracic surgery. You may be offered the scan around the time of your operation to help researchers learn how well it works.
Hear when a new Non-Small Cell Lung Cancer NSCLC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.